Dorottya Laczkó
- Co-authors
- Hiromi MuramatsuNorbert PardiJames HeyesPeter LutwycheKieu LamCsaba BajuszKatalin KarikóMohamad‐Gabriel Alameh
- Topics
- IL-33, ST2, and ILC Pathways (3 papers)Esophageal and GI Pathology (2 papers)RNA Interference and Gene Delivery (2 papers)
- Partner nations
- United StatesHungaryGermany
In The Last Decade
Dorottya Laczkó
9 papers receiving 550 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Molecular Biology 412
- Immunology 122
- Infectious Diseases 100
- Oncology 97
- Genetics 80
Countries citing papers authored by Dorottya Laczkó
This map shows the geographic impact of Dorottya Laczkó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorottya Laczkó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorottya Laczkó more than expected).
Fields of papers citing papers by Dorottya Laczkó
This network shows the impact of papers produced by Dorottya Laczkó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorottya Laczkó. The network helps show where Dorottya Laczkó may publish in the future.
Co-authorship network of co-authors of Dorottya Laczkó
This figure shows the co-authorship network connecting the top 25 collaborators of Dorottya Laczkó. A scholar is included among the top collaborators of Dorottya Laczkó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorottya Laczkó. Dorottya Laczkó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccinebreakdown → | 198 |
| 3 | 94 | |
| 4 | Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPsbreakdown → | 183 |
| 5 | 26 | |
| 6 | 19 | |
| 7 | 7 | |
| 8 | 12 | |
| 9 | 22 |
About Dorottya Laczkó
Dorottya Laczkó is a scholar working on Immunology, Gastroenterology and Clinical Biochemistry, having authored 9 papers that have together received 563 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (3 papers), Esophageal and GI Pathology (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Nephrology (55 citations), Molecular Biology (412 citations) and Immunology (122 citations). Dorottya Laczkó has collaborated with scholars based in United States, Hungary and Germany. Frequent co-authors include Hiromi Muramatsu, Norbert Pardi, James Heyes, Peter Lutwyche, Kieu Lam, Csaba Bajusz, Katalin Karikó, Mohamad‐Gabriel Alameh, István Tombácz and Amir Yadegari. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.